Annual Cash & Cash Equivalents
$1.04B$260.38M+33.48%
Summary
- Current Value
- As of today, EXAS annual cash & cash equivalents is $1.04B, up +33.48% on
- Historical Performance
- EXAS annual cash & cash equivalents is up +0.73% over the past 3 years, and up +220.72% over the past 5 years
- All-Time High Comparison
- EXAS annual cash & cash equivalents is currently -43.59% below its historical high of $1.84B set on
- 3-Year Low Comparison
- EXAS annual cash & cash equivalents is +64.23% above its 3-year low of $632.06M reached on an earlier date
- Sector Comparison
- EXAS annual cash & cash equivalents is higher than 93.64% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $1.04B | +33.5% | +0.7% | +220.7% | +4080.9% | |
| Quarterly Cash & Cash Equivalents | $1.00B | -1.8% | +49.9% | -21.8% | +2779.1% | |
| Price | $102.11 | +80.2% | +73.6% | -22.1% | +1585.0% | |
| Annual Current Assets | $1.57B | +31.6% | +10.2% | +182.1% | +6108.2% | |
| Annual Total Liabilities | $3.77B | -0.2% | -0.5% | +209.6% | +10000.0% | |
| Annual Working Capital | $839.24M | +23.5% | -7.7% | +161.9% | +4367.4% | |
| Annual Net Income | -$1.03B | -404.0% | -72.7% | -1124.9% | -10000.0% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.04B | at high | |
| 5Y | $1.84B | N/A | -43.6% |
| All | $1.84B | -43.6% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $632.06M | N/A | +64.2% |
| 5Y | $632.06M | +64.2% | |
| All | $1.79M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of EXAS?
As of today, EXAS annual cash & cash equivalents is $1.04B
What is 1-year change in EXAS annual cash & cash equivalents?
EXAS annual cash & cash equivalents is up +33.48% year-over-year
What is 3-year change in EXAS annual cash & cash equivalents?
EXAS annual cash & cash equivalents is up +0.73% over the past 3 years
How far is EXAS annual cash & cash equivalents from its all-time high?
EXAS annual cash & cash equivalents is currently -43.59% below its historical high of $1.84B set on December 31, 2020
How does EXAS annual cash & cash equivalents rank versus sector peers?
EXAS annual cash & cash equivalents is higher than 93.64% of companies in Healthcare sector
When is EXAS next annual earnings release?
The next annual earnings release for EXAS is on
Quarterly Cash & Cash Equivalents
$1.00B$144.66M+16.85%
Summary
- Current Value
- As of today, EXAS quarterly cash & cash equivalents is $1.00B, up +16.85% on
- Historical Performance
- EXAS quarterly cash & cash equivalents is down -1.77% year-over-year, and up +49.91% over the past 3 years
- All-Time High Comparison
- EXAS quarterly cash & cash equivalents is currently -45.48% below its historical high of $1.84B set on
- 3-Year Low Comparison
- EXAS quarterly cash & cash equivalents is +58.70% above its 3-year low of $632.06M reached on an earlier date
- Sector Comparison
- EXAS quarterly cash & cash equivalents is higher than 92.74% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $1.00B | +16.9% | -1.8% | +49.9% | -21.8% | |
| Annual Cash & Cash Equivalents | $1.04B | – | +33.5% | +0.7% | +220.7% | |
| Price | $102.11 | +71.7% | +80.2% | +73.6% | -22.1% | |
| Quarterly Current Assets | $1.59B | +5.5% | +3.8% | +51.7% | -1.0% | |
| Quarterly Total Liabilities | $3.40B | +2.1% | -3.9% | +6.3% | +68.5% | |
| Quarterly Working Capital | $1.01B | +2.1% | +24.3% | +61.1% | -25.7% | |
| Quarterly Net Income | -$19.59M | -1553.5% | +48.8% | +86.8% | +90.3% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.04B | N/A | -3.4% |
| 3Y | $1.04B | -3.4% | |
| 5Y | $1.84B | N/A | -45.5% |
| All | $1.84B | -45.5% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $786.18M | +27.6% | |
| 3Y | $632.06M | N/A | +58.7% |
| 5Y | $632.06M | +58.7% | |
| All | $62.60K | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of EXAS?
As of today, EXAS quarterly cash & cash equivalents is $1.00B
What is EXAS quarterly cash & cash equivalents most recent change?
EXAS quarterly cash & cash equivalents was up +16.85% on September 30, 2025
What is 1-year change in EXAS quarterly cash & cash equivalents?
EXAS quarterly cash & cash equivalents is down -1.77% year-over-year
How far is EXAS quarterly cash & cash equivalents from its all-time high?
EXAS quarterly cash & cash equivalents is currently -45.48% below its historical high of $1.84B set on December 31, 2020
How does EXAS quarterly cash & cash equivalents rank versus sector peers?
EXAS quarterly cash & cash equivalents is higher than 92.74% of companies in Healthcare sector
When is EXAS next earnings release?
The next earnings release for EXAS is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- EXAS Official Website www.exactsciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1124140/000112414025000091/0001124140-25-000091-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124140/000112414025000020/0001124140-25-000020-index.htm
- EXAS Profile on Yahoo Finance finance.yahoo.com/quote/EXAS
- EXAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exas